Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer

NCT01308567 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1168

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Cabazitaxel (XRP6258)
DRUG: Docetaxel (XRP6976)
DRUG: Prednisone

Sponsor

Sanofi